Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.100 |
None |
1.000 |
17 |
|
1998 |
2015 |
Neoplasm Metastasis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6385
|
327
|
0.080 |
None |
1.000 |
8 |
|
2007 |
2017 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.070 |
None |
1.000 |
7 |
|
2005 |
2017 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.070 |
None |
1.000 |
7 |
|
2005 |
2017 |
Mammary Neoplasms
|
group |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
2780
|
385
|
0.060 |
None |
1.000 |
6 |
|
2005 |
2017 |
Tumor Cell Invasion
|
phenotype |
|
Neoplastic Process
|
6626
|
169
|
0.060 |
None |
1.000 |
6 |
|
2008 |
2019 |
Ovarian clear cell carcinoma
|
disease |
|
Neoplastic Process
|
103
|
|
0.060 |
None |
1.000 |
6 |
|
2012 |
2018 |
Carcinoma, Ovarian Epithelial
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Neoplastic Process
|
2841
|
327
|
0.060 |
None |
1.000 |
6 |
|
2002 |
2014 |
Tumor Progression
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Neoplastic Process
|
3865
|
72
|
0.050 |
None |
1.000 |
5 |
|
2007 |
2010 |
ovarian neoplasm
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Neoplastic Process
|
2542
|
757
|
0.050 |
None |
1.000 |
5 |
|
2002 |
2014 |
Malignant neoplasm of ovary
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Neoplastic Process
|
2563
|
315
|
0.050 |
None |
1.000 |
5 |
|
2002 |
2014 |
Carcinogenesis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6243
|
355
|
0.040 |
None |
1.000 |
4 |
|
2014 |
2015 |
Prostate carcinoma
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
4388
|
1168
|
0.030 |
None |
1.000 |
3 |
|
2013 |
2016 |
Malignant neoplasm of prostate
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
4502
|
1082
|
0.030 |
None |
1.000 |
3 |
|
2013 |
2016 |
Carcinoma
|
group |
Neoplasms
|
Neoplastic Process
|
2462
|
103
|
0.030 |
None |
1.000 |
3 |
|
2003 |
2012 |
Polycystic Ovary Syndrome
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Disease or Syndrome
|
988
|
363
|
0.020 |
None |
1.000 |
2 |
|
2017 |
2020 |
estrogen receptor-negative breast cancer
|
disease |
|
Neoplastic Process
|
356
|
40
|
0.020 |
None |
1.000 |
2 |
|
2014 |
2014 |
Secondary Neoplasm
|
group |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
2492
|
85
|
0.020 |
None |
1.000 |
2 |
|
2007 |
2012 |
Oestrogen receptor positive breast cancer
|
disease |
|
Neoplastic Process
|
510
|
58
|
0.020 |
None |
1.000 |
2 |
|
2014 |
2014 |
Malignant neoplasm of colon and/or rectum
|
disease |
|
Neoplastic Process
|
3669
|
502
|
0.020 |
None |
1.000 |
2 |
|
2015 |
2015 |
Secondary malignant neoplasm of lymph node
|
disease |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
2825
|
188
|
0.020 |
None |
1.000 |
2 |
|
2009 |
2012 |
Prostatic Cancer, Castration-Resistant
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
12
|
|
0.300 |
None |
1.000 |
1 |
|
2018 |
2018 |
Prostatic Neoplasms, Castration-Resistant
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
9
|
|
0.300 |
None |
1.000 |
1 |
|
2018 |
2018 |
Secondary malignant neoplasm of liver
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
951
|
34
|
0.010 |
None |
1.000 |
1 |
|
2000 |
2000 |
Sezary Syndrome
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
196
|
7
|
0.010 |
None |
1.000 |
1 |
|
2003 |
2003 |